Sonnet BioTherapeutics Holdings, Inc. (SONN)
NASDAQ: SONN · Real-Time Price · USD
1.440
+0.010 (0.70%)
Feb 21, 2025, 4:00 PM EST - Market closed
SONN Balance Sheet
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2019 - 2018 |
| Cash & Equivalents | 4.86 | 0.15 | 2.27 | 3.05 | 27.62 | 7.35 | Upgrade
|
| Cash & Short-Term Investments | 4.86 | 0.15 | 2.27 | 3.05 | 27.62 | 7.35 | Upgrade
|
| Cash Growth | 60.90% | -93.43% | -25.50% | -88.95% | 275.82% | 20515.10% | Upgrade
|
| Other Receivables | 0.67 | 0.76 | 0.79 | 0.72 | - | - | Upgrade
|
| Receivables | 0.67 | 0.76 | 0.79 | 0.72 | - | - | Upgrade
|
| Prepaid Expenses | 1.2 | 1.21 | 1.68 | 1.64 | 1.19 | 0.29 | Upgrade
|
| Total Current Assets | 6.73 | 2.12 | 4.74 | 5.41 | 28.81 | 7.64 | Upgrade
|
| Property, Plant & Equipment | 0.12 | 0.14 | 0.23 | 0.3 | 0.18 | 0.27 | Upgrade
|
| Long-Term Deferred Charges | 0.12 | 0.02 | 0.05 | 0.11 | - | - | Upgrade
|
| Other Long-Term Assets | 0.21 | 0.49 | 0.41 | - | - | 0.08 | Upgrade
|
| Total Assets | 7.18 | 2.77 | 5.43 | 5.83 | 28.99 | 7.99 | Upgrade
|
| Accounts Payable | 1.64 | 2.18 | 2.2 | 4.75 | 3.78 | 2.06 | Upgrade
|
| Accrued Expenses | 1.39 | 0.94 | 3.23 | 3.19 | 2.31 | 2.06 | Upgrade
|
| Short-Term Debt | - | - | - | 0 | 0 | 0.02 | Upgrade
|
| Current Portion of Leases | 0.09 | 0.08 | 0.07 | 0.05 | 0.09 | 0.08 | Upgrade
|
| Current Unearned Revenue | - | - | 0.02 | 0.17 | 0.52 | 0.5 | Upgrade
|
| Other Current Liabilities | 0 | 0 | 0 | 0 | - | - | Upgrade
|
| Total Current Liabilities | 3.12 | 3.21 | 5.52 | 8.16 | 6.7 | 4.72 | Upgrade
|
| Long-Term Debt | - | - | - | - | - | 0.12 | Upgrade
|
| Long-Term Leases | 0.02 | 0.05 | 0.13 | 0.2 | 0.03 | 0.13 | Upgrade
|
| Total Liabilities | 3.15 | 3.26 | 5.66 | 8.37 | 6.73 | 4.97 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 124.88 | 117.2 | 110.02 | 88.87 | 83.95 | 39.72 | Upgrade
|
| Retained Earnings | -120.84 | -117.68 | -110.24 | -91.41 | -61.69 | -36.71 | Upgrade
|
| Shareholders' Equity | 4.04 | -0.49 | -0.23 | -2.54 | 22.26 | 3.02 | Upgrade
|
| Total Liabilities & Equity | 7.18 | 2.77 | 5.43 | 5.83 | 28.99 | 7.99 | Upgrade
|
| Total Debt | 0.11 | 0.13 | 0.2 | 0.26 | 0.13 | 0.35 | Upgrade
|
| Net Cash (Debt) | 4.75 | 0.02 | 2.07 | 2.8 | 27.5 | 7 | Upgrade
|
| Net Cash Growth | 67.59% | -99.10% | -25.98% | -89.83% | 292.99% | - | Upgrade
|
| Net Cash Per Share | 4.56 | 0.03 | 15.96 | 113.31 | - | - | Upgrade
|
| Filing Date Shares Outstanding | 3.07 | 3.01 | 0.38 | 0.05 | 0.02 | - | Upgrade
|
| Total Common Shares Outstanding | 3.01 | 0.65 | 0.22 | 0.03 | 0.02 | - | Upgrade
|
| Working Capital | 3.6 | -1.09 | -0.79 | -2.75 | 22.11 | 2.91 | Upgrade
|
| Book Value Per Share | 1.34 | -0.75 | -1.03 | -80.59 | 910.35 | - | Upgrade
|
| Tangible Book Value | 4.04 | -0.49 | -0.23 | -2.54 | 22.26 | 3.02 | Upgrade
|
| Tangible Book Value Per Share | 1.34 | -0.75 | -1.03 | -80.59 | 910.35 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.